{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T20:29:46Z","timestamp":1793478586156,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156703","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:29:46Z","timestamp":1790688586000},"page":"156703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A\/MMP9 axis: An integrated bioinformatics and experimental study"],"prefix":"10.1016","volume":"288","author":[{"given":"Yingying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2026.156703_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156703_bib2","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2026.156703_bib3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2026.156703_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218437","article-title":"The hallmarks of pancreatic cancer","volume":"650","author":"Kane","year":"2026","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2026.156703_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI191942","article-title":"Challenges of early detection of pancreatic cancer","volume":"135","author":"Shen","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.prp.2026.156703_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/0115701646317271240821071544","article-title":"Comprehensive analysis of tertiary lymphoid structures in pancreatic cancer: molecular characteristics and prognostic implications","volume":"21","author":"Jiana","year":"2024","journal-title":"Curr. Proteom."},{"key":"10.1016\/j.prp.2026.156703_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41392-025-02499-y","article-title":"Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies","volume":"11","author":"Rozengurt","year":"2026","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.prp.2026.156703_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1126\/science.aef6665","article-title":"KRAShing pancreatic cancer before takeoff","volume":"391","author":"Neel","year":"2026","journal-title":"Science"},{"key":"10.1016\/j.prp.2026.156703_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/14737140.2024.2357802","article-title":"The trend toward more target therapy in pancreatic ductal adenocarcinoma","volume":"24","author":"Deiana","year":"2024","journal-title":"Expert. Rev. Anticancer. Ther."},{"key":"10.1016\/j.prp.2026.156703_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004485","article-title":"Detection of microsatellite instability-high (MSI-H) by liquid biopsy predicts robust and durable response to immunotherapy in patients with pancreatic cancer","volume":"10","author":"Chakrabarti","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.prp.2026.156703_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13045-024-01613-x","article-title":"Consensus, debate, and prospective on pancreatic cancer treatments","volume":"17","author":"Wang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.prp.2026.156703_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115647","article-title":"Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies","volume":"224","author":"du Toit-Thompson","year":"2025","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.prp.2026.156703_bib13","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i43.111433","article-title":"Pancreatic cancer in 2025: have we found a solution?","volume":"31","author":"Tonini","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156703_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","article-title":"Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system","volume":"41","author":"Schuth","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156703_bib15","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1007\/s11864-023-01146-4","article-title":"Current status of complementary and alternative medicine interventions in the management of pancreatic cancer - An overview","volume":"24","author":"Tarasiuk","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.prp.2026.156703_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/cancers17091437","article-title":"Unconventional treatments for pancreatic cancer: a systematic review","volume":"17","author":"Vella","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156703_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12943-024-02136-2","article-title":"Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery","volume":"23","author":"Wu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.prp.2026.156703_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/0109298665363165250225100109","article-title":"Unveiling the potential role of Hesperetin and Emodin as a combination therapy to inhibit the pancreatic cancer progression against the C-Met gene","volume":"32","author":"Kaviyaprabha","year":"2025","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.prp.2026.156703_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13046-018-1015-9","article-title":"Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway","volume":"38","author":"Yang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.prp.2026.156703_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3390\/toxins16070285","article-title":"Rhein inhibits cell development and aflatoxin biosynthesis via energy supply disruption and ROS accumulation in Aspergillus flavus","volume":"16","author":"Wang","year":"2024","journal-title":"Toxins"},{"key":"10.1016\/j.prp.2026.156703_bib21","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.3390\/ph17121665","article-title":"Rhein: an updated review concerning its biological activity, pharmacokinetics, structure optimization, and future pharmaceutical applications","volume":"17","author":"Fu","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.prp.2026.156703_bib22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jare.2025.11.056","article-title":"Rhein alleviates acute pancreatitis by inhibiting TMAO-mediated inflammatory signaling pathways and reducing acinar cell injury","volume":"86","author":"Zhang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.prp.2026.156703_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155156","article-title":"Targeting HSP70 chaperones by rhein sensitizes liver cancer to artemisinin derivatives","volume":"122","author":"Wang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.prp.2026.156703_bib24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.7150\/ijbs.49514","article-title":"Inhibition of PI3K\/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells","volume":"17","author":"Liu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.prp.2026.156703_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1035882","article-title":"Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy","volume":"13","author":"Cui","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156703_bib26","doi-asserted-by":"crossref","first-page":"10090","DOI":"10.3390\/biom16010090","article-title":"Natural product driven activation of UCP1 and tumor metabolic suppression: integrating thermogenic nutrient competition with cancer metabolic reprogramming","volume":"16","author":"Moon","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.prp.2026.156703_bib27","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.7150\/thno.107812","article-title":"Mitochondria-targeting natural product rhein conjugated with dichloroacetate as the dual inhibitor of glycolysis and oxidative phosphorylation to off energize cancer cells and induce ROS storm","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.prp.2026.156703_bib28","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41540-025-00601-2","article-title":"MMP9 shapes cell mechanics to enable collective invasion in cancer","volume":"11","author":"Asadullah","year":"2025","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.prp.2026.156703_bib29","article-title":"Pan-cancer analysis of the prognostic and immunological role of matrix metalloproteinase 9","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine"},{"key":"10.1016\/j.prp.2026.156703_bib30","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1111\/febs.16046","article-title":"The gate to metastasis: key players in cancer cell intravasation","volume":"289","author":"Sznurkowska","year":"2022","journal-title":"Febs J."},{"key":"10.1016\/j.prp.2026.156703_bib31","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1038\/s41467-024-54920-9","article-title":"The dysadherin\/MMP9 axis modifies the extracellular matrix to accelerate colorectal cancer progression","volume":"15","author":"Lee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.prp.2026.156703_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.113060","article-title":"TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma","volume":"28","author":"Luo","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.prp.2026.156703_bib33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1186\/s12967-026-07926-4","article-title":"TFAP2A regulates SGPP2 transcription to promote lipid accumulation and activate the Wnt\/\u03b2-catenin signaling pathway to promote malignant progression in lung adenocarcinoma","volume":"24","author":"Li","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2026.156703_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41420-024-02251-5","article-title":"TFAP2A drives non-small cell lung cancer (NSCLC) progression and resistance to targeted therapy by facilitating the ESR2-mediated MAPK pathway","volume":"10","author":"Wang","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.prp.2026.156703_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s41065-025-00524-2","article-title":"TFAP2A promotes NSCLC malignant progression by enhancing AOC1 transcription","volume":"162","author":"Miao","year":"2025","journal-title":"Hereditas"},{"key":"10.1016\/j.prp.2026.156703_bib36","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000536557","article-title":"TFAP2A upregulates SKA3 to promote glycolysis and reduce the sensitivity of lung adenocarcinoma cells to cisplatin","volume":"109","author":"Liu","year":"2024","journal-title":"Pharmacology"},{"key":"10.1016\/j.prp.2026.156703_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s42003-025-08338-8","article-title":"Super-enhancers orchestrate transcriptional dysregulation and metabolic reprogramming in uveal melanoma","volume":"8","author":"Pan","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.prp.2026.156703_bib38","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.2147\/DDDT.S515409","article-title":"Rhein alleviates cisplatin-induced acute kidney injury via downregulation of NOX4-COX2\/PGFS signaling pathway","volume":"19","author":"Yuan","year":"2025","journal-title":"Drug. Des. Devel. Ther."},{"key":"10.1016\/j.prp.2026.156703_bib39","doi-asserted-by":"crossref","first-page":"828","DOI":"10.3748\/wjg.v26.i8.828","article-title":"Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer","volume":"26","author":"Xu","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.prp.2026.156703_bib40","doi-asserted-by":"crossref","first-page":"9693","DOI":"10.2147\/IJN.S226628","article-title":"Epidermal growth factor receptor and its role in pancreatic cancer treatment mediated by nanoparticles","volume":"14","author":"Grapa","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.prp.2026.156703_bib41","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.3390\/ijms21124526","article-title":"The impact of matrix metalloproteinase-9 on the sequential steps of the metastatic process","volume":"21","author":"Barillari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2026.156703_bib42","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.3390\/pharmaceutics17111425","article-title":"Matrix metalloproteinase-9 (MMP-9) as a therapeutic target: insights into molecular pathways and clinical applications","volume":"17","author":"Wolosowicz","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.prp.2026.156703_bib43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12967-023-04189-1","article-title":"Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views","volume":"21","author":"Jin","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2026.156703_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70087","article-title":"TFAP2A promotes cell progression and suppresses ferroptosis in lung adenocarcinoma via activating transcription of CST1","volume":"39","author":"Luan","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.prp.2026.156703_bib45","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s00210-025-04359-6","article-title":"Transcription factor TFAP2A drives the growth and metastasis and blocks ferroptosis of triple-negative breast cancer by activating PRAME transcription","volume":"399","author":"Pei","year":"2026","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"key":"10.1016\/j.prp.2026.156703_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1021\/acsmedchemlett.2c00545","article-title":"A shift in thinking: cellular thermal shift assay-enabled drug discovery","volume":"14","author":"Caballero","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.prp.2026.156703_bib47","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s00018-015-2098-5","article-title":"Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway","volume":"73","author":"Payen","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.prp.2026.156703_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2407-14-181","article-title":"SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells","volume":"14","author":"Chen","year":"2014","journal-title":"BMC Cancer"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:40:58Z","timestamp":1793475658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":48,"alternative-id":["S0344033826003560"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156703","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rhein suppresses pancreatic cancer progression and glycolysis by inhibiting the TFAP2A\/MMP9 axis: An integrated bioinformatics and experimental study","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156703","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156703"}}